Opokan Artro
Natural health product licensed in Canada
- Other names
- Opokan
- Licence holder
- Kaborex Inc.
- NPN or DIN-HM
- 80094935
- Status
- Active licence
- Licence date
- 18 October 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Stem bark oleogum resin | 20 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 500 mg | Not calculated |
Non-medicinal ingredients
Sels de magnésium d'acides gras, Gélatine, C.I. n° 77891, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
A factor in maintaining healthy cartilage and/or joint health. Helps in collagen formation to maintain healthy bones. Helps in the development and maintenance of bones. Helps to protect against the deterioration of cartilage. Helps to relieve joint pain and swelling associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Stop use if diarrhea, abdominal pain, heartburn, nausea or vomiting occur.
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80094935
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.